EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / ADS
Total 13F shares
226,325
Share change
-451,606
Total reported value
$441,000
Put/Call ratio
7.1%
Price per share
$1.95
Number of holders
7
Value change
-$1,402,037
Number of buys
2
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVAXION BIOTECH A S - ADS (EVAX) as of Q2 2022

As of 30 Jun 2022, EVAXION BIOTECH A S - ADS (EVAX) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 226,325 shares. The largest 7 holders included Telemetry Investments, L.L.C., CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CITIGROUP INC, UBS Group AG, and Steward Partners Investment Advisory, LLC. This page lists 7 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.